- Home
- ULH vs BCYC Comparison
ULH vs BCYC Comparison
Compare ULH & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- BCYC
- Stock Information
- Founded
- ULH 1932
- BCYC 2009
- Country
- ULH United States
- BCYC United Kingdom
- Employees
- ULH N/A
- BCYC N/A
- Industry
- ULH Trucking Freight/Courier Services
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- ULH Industrials
- BCYC Health Care
- Exchange
- ULH Nasdaq
- BCYC Nasdaq
- Market Cap
- ULH 397.8M
- BCYC 438.4M
- IPO Year
- ULH 2005
- BCYC 2019
- Fundamental
- Price
- ULH $15.12
- BCYC $7.51
- Analyst Decision
- ULH Hold
- BCYC Buy
- Analyst Count
- ULH 1
- BCYC 11
- Target Price
- ULH $24.00
- BCYC $18.73
- AVG Volume (30 Days)
- ULH 63.9K
- BCYC 394.1K
- Earning Date
- ULH 11-06-2025
- BCYC 10-30-2025
- Dividend Yield
- ULH 2.78%
- BCYC N/A
- EPS Growth
- ULH N/A
- BCYC N/A
- EPS
- ULH N/A
- BCYC N/A
- Revenue
- ULH $1,638,101,000.00
- BCYC $28,339,000.00
- Revenue This Year
- ULH N/A
- BCYC N/A
- Revenue Next Year
- ULH $5.57
- BCYC N/A
- P/E Ratio
- ULH N/A
- BCYC N/A
- Revenue Growth
- ULH N/A
- BCYC N/A
- 52 Week Low
- ULH $12.78
- BCYC $6.03
- 52 Week High
- ULH $52.39
- BCYC $21.50
- Technical
- Relative Strength Index (RSI)
- ULH 44.55
- BCYC 57.71
- Support Level
- ULH $12.78
- BCYC $6.03
- Resistance Level
- ULH $15.98
- BCYC $6.75
- Average True Range (ATR)
- ULH 1.02
- BCYC 0.44
- MACD
- ULH 0.38
- BCYC 0.14
- Stochastic Oscillator
- ULH 71.46
- BCYC 82.22
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.